HIV

CROI 2023 – GSK and Gilead’s long-acting HIV battle intensifies
EP Vantage
Mon, 02/27/23 - 07:01 pm
GSK
Gilead Sciences
CROI
Cabenuva
HIV
GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill
Yahoo/Reuters
Fri, 02/24/23 - 09:08 am
GSK
HIV
ViiV Healthcare
Gilead Sciences
Cabenuva
Biktarvy
Gilead Sciences reports positive data from HIV therapy trial
Clinical Trials Arena
Thu, 02/23/23 - 10:12 am
Gilead Sciences
lenacapavir
HIV
clinical trials
Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table
Fierce Pharma
Wed, 02/22/23 - 06:54 pm
Gilead Sciences
legal
HIV
antitrust
Teva Pharmaceutical
JNJ
Oncology, HIV sales lift Gilead’s revenues by 2%
Medical Marketing and Media
Thu, 02/2/23 - 11:09 pm
Gilead Sciences
earnings
HIV
oncology
hepatitis C
J&J packs up HIV vaccine after failing phase 3 trial
Fierce Biotech
Wed, 01/18/23 - 11:06 am
JNJ
vaccines
HIV
HIV vaccines
clinical trials
FDA approves drugs from Gilead, Roche, TG Therapeutics to close 2022
BioPharma Dive
Wed, 01/4/23 - 10:11 am
FDA
drug approvals
HIV
lymphoma
multiple sclerosis
Gilead Sciences
Roche
TG Therapeutics
Gilead goes long-acting in HIV
EP Vantage
Fri, 12/23/22 - 10:35 am
Gilead Sciences
lenacapavir
HIV
FDA
Federal claims court rules in favor of Gilead in CDC Truvada patent case
Endpoints
Thu, 12/1/22 - 07:08 pm
Gilead Sciences
Truvada
PrEP
HIV
CDC
patents
GSK's ViiV gives early look at HIV broadly neutralizing antibody's power, eyes long-acting combo trial
Fierce Biotech
Tue, 10/25/22 - 10:58 am
GSK
ViiV
bNab
N6LS
HIV
4 Biotech Stocks With Huge Incoming Catalysts
Motley Fool
Wed, 10/12/22 - 11:03 am
FDA
Biogen
Eisai
Alzheimer's disease
Gilead Sciences
HIV
Mirati Therapeutics
lung cancer
lecanemab
lenacapavir
adagrasib
Gilead targets 'large-scale' HIV drugs counterfeiting scheme as judge orders asset freeze
Fierce Pharma
Thu, 09/29/22 - 07:40 pm
Gilead Sciences
HIV
drug counterfeiting
legal
GSK, still early in US launch, licenses long-acting HIV PrEP drug Apretude to patent pool for poorer nations
Fierce Pharma
Thu, 07/28/22 - 12:33 pm
GSK
HIV
PrEP
Apretude
Medicines Patent Pool
AIDS 2022 preview – Gilead shoots for an HIV cure
EP Vantage
Wed, 07/27/22 - 10:27 am
Gilead Sciences
HIV
AIDS
Gilead doubles down on HIV prevention, treatment amid Covid setbacks and awaiting FDA decision on long-acting candidate
Endpoints
Thu, 07/21/22 - 09:46 pm
Gilead
HIV
FDA
Gilead tries again with twice-yearly HIV drug lenacapavir
Pharmaforum
Tue, 06/28/22 - 05:52 pm
Gilead Sciences
HIV
FDA
lenacapavir
Gilead nets $33M in settlement over yearslong HIV drug fraud case in Florida
Fierce Pharma
Tue, 06/28/22 - 10:41 am
Gilead Sciences
HIV
fraud
Florida
legal
Bristol Myers settles anti-generic HIV drug scheme allegations for almost $11M
Endpoints
Wed, 06/8/22 - 10:18 am
Bristol Myers Squibb
legal
HIV
generics
competition
California
Gilead HIV prospect escapes FDA hold after glass compatibility glitch triggered regulatory setbacks
Fierce Pharma
Tue, 05/17/22 - 10:34 am
Gilead Sciences
drug manufacturing
FDA
HIV
lenacapavir
Is Gilead Sciences Too Dependent On These 2 Areas of Its Business?
Motley Fool
Sun, 05/8/22 - 12:17 pm
Gilead Sciences
COVID-19
Veklury
earnings
HIV

Pages